Dimensional Fund Advisors LP Boosts Stake in Henry Schein, Inc. $HSIC

Dimensional Fund Advisors LP increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 6.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,596,168 shares of the company’s stock after acquiring an additional 159,087 shares during the period. Dimensional Fund Advisors LP owned approximately 2.21% of Henry Schein worth $172,304,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. CYBER HORNET ETFs LLC acquired a new stake in Henry Schein in the second quarter valued at $25,000. MUFG Securities EMEA plc acquired a new position in shares of Henry Schein during the 2nd quarter worth $27,000. Sentry Investment Management LLC increased its holdings in shares of Henry Schein by 132.1% in the 3rd quarter. Sentry Investment Management LLC now owns 905 shares of the company’s stock valued at $59,000 after purchasing an additional 515 shares in the last quarter. Evelyn Partners Investment Management Services Ltd purchased a new position in shares of Henry Schein in the 2nd quarter valued at about $62,000. Finally, Mather Group LLC. acquired a new stake in shares of Henry Schein in the third quarter valued at about $71,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. JPMorgan Chase & Co. upped their target price on shares of Henry Schein from $78.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 25th. Wall Street Zen raised Henry Schein from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 28th. Leerink Partners restated a “market perform” rating on shares of Henry Schein in a report on Monday. Wells Fargo & Company raised their price objective on Henry Schein from $76.00 to $87.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 25th. Finally, Barrington Research set a $97.00 price objective on Henry Schein and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $85.58.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 2,844 shares of the company’s stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $80.36, for a total value of $228,543.84. Following the sale, the director owned 21,961 shares of the company’s stock, valued at approximately $1,764,785.96. This represents a 11.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Mark E. Mlotek sold 5,925 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $80.80, for a total value of $478,740.00. Following the sale, the executive vice president owned 80,554 shares in the company, valued at approximately $6,508,763.20. This trade represents a 6.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 101,712 shares of company stock valued at $8,251,789. 1.14% of the stock is owned by corporate insiders.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $78.10 on Tuesday. The company has a current ratio of 1.38, a quick ratio of 0.76 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $8.96 billion, a P/E ratio of 23.88, a price-to-earnings-growth ratio of 2.30 and a beta of 0.87. The firm has a 50-day moving average price of $78.23 and a two-hundred day moving average price of $72.70. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $89.29.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 24th. The company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.04. The company had revenue of $3.44 billion for the quarter, compared to the consensus estimate of $3.34 billion. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.19 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.